Thijs Cohen Tervaert is a Partner at Inkef and has been with Inkef since 2016. Prior to Inkef, he was a strategy consultant at the Boston Consulting Group with a focus on health care and technology. He worked on projects advising clients in the pharmaceutical industry, health insurers and large hospital systems and has helped to establish the Amsterdam Health and Technology Institute in 2014. Thijs is a medical doctor who graduated at Leiden University. He has also co-authored several scientific papers in the field of diabetes.
Thijs currently also serves on the board of iOnctura, ViCentra and Castor and has previously served on the board of Aidence (acquired by RadNet) and Calypso Biotech (acquired by Novartis).